Prevalence of asthma among Middle Eastern children: A systematic review

Masoud Mirzaei1, Mehran Karimi2, Shima Beheshti3

  • 1Yazd Cardiovascular Research Centre, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Insights

This systematic review found the prevalence of childhood asthma in the Middle East to be 7.53%. While lower than in developed countries, more longitudinal data is needed for trend analysis.

Area of Science:

  • Pediatric Allergy and Immunology
  • Epidemiology
  • Public Health

Background:

  • Global rise in childhood asthma and allergy necessitates regional data.
  • Limited epidemiological data exists for asthma prevalence in Middle Eastern children.
  • This review addresses the knowledge gap regarding childhood asthma in the Middle East.

Purpose of the Study:

  • To systematically review and estimate the prevalence of asthma among children in the Middle East.
  • To synthesize existing epidemiological data on childhood asthma in the region.
  • To identify potential variations in prevalence based on age and sex.

Main Methods:

  • Systematic search of local and international databases (SID, Iranmedex, Medline, Science Direct) from 1996-2011.
  • Inclusion of studies meeting defined criteria, including those using International Study of Asthma and Allergies in Childhood (ISAAC) criteria.
  • Meta-analysis using a random-effect model, with heterogeneity and publication bias assessed.

Main Results:

  • Fifty studies encompassing 289,717 children were included, with asthma prevalence ranging from 0.7% to 22.3%.
  • The overall pooled prevalence of diagnosed asthma was 7.53% (95% CI: 6.38-8.75).
  • Prevalence was similar in 6-7 year olds (7.43%) and 13-14 year olds (7.57%), with higher rates in boys (8.91%) than girls (6.30%).

Conclusions:

  • Childhood asthma prevalence in the Middle East is lower compared to many developed nations.
  • Current data is insufficient for longitudinal trend analysis of asthma prevalence over time.
  • Standardized epidemiological studies are recommended for accurate regional estimates and public health planning.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K